Exponent, Inc. (NASDAQ:EXPO) Stock to Pay Quarterly Dividend of $0.31

Exponent, Inc. (NASDAQ:EXPO) announced a quarterly dividend on Thursday, October 29th. Investors of record on Friday, December 4th will be given a dividend of $0.31 per share by the business services provider on Friday, December 18th. This represents a $1.24 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date is Friday, December 4th.

Exponent has increased its dividend by an average of 0.1% per year over the last three years and has raised its dividend annually for the last 12 consecutive years. Exponent has a payout ratio of 57.9% meaning its dividend is sufficiently covered by earnings. Analysts expect Exponent to earn $2.67 per share next year, which means the company should continue to be able to cover its $1.24 annual dividend with an expected future payout ratio of 46.4%.

Exponent Stock Performance

Shares of EXPO stock opened at $78.31 on Friday. The company has a market capitalization of $3.72 billion, a P/E ratio of 35.12 and a beta of 0.69. The company’s 50 day moving average price is $69.97 and its two-hundred day moving average price is $66.61. Exponent has a 52 week low of $51.91 and a 52 week high of $81.95.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Thursday, October 29th. The business services provider reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.60 by $0.04. The company had revenue of $173.73 million during the quarter, compared to analysts’ expectations of $149.64 million. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The business’s quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.55 earnings per share. Analysts forecast that Exponent will post 2.31 earnings per share for the current year.

Trending Headlines about Exponent

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Q3 earnings and revenue beat estimates: Exponent reported adjusted earnings of $0.64 per share versus the $0.60 consensus estimate. Revenue reached $173.7 million, substantially above analysts’ $149.6 million forecast, and increased from the prior-year period. Exponent earnings report
• Positive Sentiment: Profitability and cash generation remained solid: Net income was approximately $30.9 million, operating profit rose 44.2% to $41.9 million, and operating cash flow totaled $30.9 million. The results suggest operating leverage as revenue expanded. Exponent Q3 financial results
• Positive Sentiment: 2026 outlook raised: Management reportedly increased its full-year outlook following the strong quarter, improving expectations for future earnings and supporting the investment case. Exponent raises 2026 outlook
• Positive Sentiment: Quarterly dividend maintained: The board declared a $0.31-per-share dividend payable December 18 to shareholders of record December 4. The annualized payout is $1.24 per share, representing a yield of about 1.6%. Exponent dividend announcement
• Neutral Sentiment: Potential acquisition: Exponent was reported to be acquiring Crane Building Services & Utilities in a carve-out transaction. Financial terms and the expected earnings impact were not provided, leaving the near-term effect uncertain. Exponent acquisition report
• Negative Sentiment: Insider selling and valuation are risks: Reported insider activity over the past six months included substantially more sales than purchases. In addition, EXPO’s price-to-earnings ratio is about 35, leaving the stock vulnerable to profit-taking if growth or guidance disappoints.

Exponent Company Profile

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.